Aeterna Zentaris
AEZS
$2.79
Share price
0.54%
Change (1 day)
-46.86%
Change (1 year)
Categories
Aeterna Zentaris (AEZS) - Total debt
Total debt on the balance sheet as of December 2022 : $0.17 M
According to Aeterna Zentaris's latest financial reports the company's total debt is $0.17 M. A company’s total debt is the sum of all current and non-current debts.
Aeterna Zentaris - Total debt on balance sheet (from 2001 to 2022)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2021-12-31 | $0.16 M | -12.5% |
| 2020-12-31 | $0.18 M | -79.62% |
| 2019-12-31 | $0.9 M | |
| 2011-12-31 | $0.07 M | -52.67% |
| 2010-12-31 | $0.15 M | -25% |
| 2009-12-31 | $0.2 M | -9.5% |
| 2008-12-31 | $0.22 M | -71.48% |
| 2007-12-31 | $0.77 M | -45.54% |
| 2006-12-31 | $1.42 M | -98.96% |
| 2005-12-31 | $0.13 B | 114.87% |
| 2004-12-31 | $63.54 M | 112.22% |
| 2003-12-31 | $29.94 M | -16.08% |
| 2002-12-31 | $35.67 M | 310.16% |
| 2001-12-31 | $8.69 M |
Total debt for similar companies or competitors
| Company | Total debt | differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $29.20 B | 16,314,983.80% | 🇨🇭 Switzerland |
 Sanofi SNY | $22.71 B | 12,691,240.78% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | $39.37 B | 21,994,872.07% | 🇺🇸 USA |
 Spectrum Pharmaceuticals
SPPI | $28.66 M | 15,914.53% | 🇺🇸 USA |
 Halozyme Therapeutics HALO | $1.50 B | 841,296.65% | 🇺🇸 USA |